Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

First REal-life Evaluation of Darifenacin in Overactive Bladder Patients During 3 Months

NCT00921245 is registered in ClinicalTrials.gov with Bayer as lead sponsor.

NCT NCT00921245
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00921245 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
First REal-life Evaluation of Darifenacin in Overactive Bladder Patients During 3 Months
Lead sponsor
Bayer
Phase
Observational
Overall status
Completed
Start date
June 30, 2007
Completion date
February 28, 2009
Enrollment
9 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

overactive bladder